Funding round brings in $6.4M for developer of Alzheimer's drug

05/7/2013 | MedCityNews.com

NeuroPhage Pharmaceuticals secured $6.4 million in a funding round led by Mérieux Développement. The company will use the proceeds to advance development of its potential Alzheimer's drug NPT002, which is in preclinical development. The firm plans to submit an investigational new drug application and begin clinical trials next year.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL